Atlas Trials

Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer

Clinical trial NCT00203931 · TERMINATED

Trial details

NCT number
NCT00203931
Sponsor
University of Chicago
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2005-03-01
Primary completion
2008-11-01
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.